Neotherix Logo
Archived News
Open All News Items  |  Close All News Items  |  Current News  |  RSS Feed Subscribe to our RSS news feed

Older news items from Neotherix are listed below. See the Current News page for more recent articles.

19/12/13 Neotherix mentioned in editorial review of electrospun nanofibres
06/11/13 Neotherix presenting at TERMIS-AM 2013
17/10/13 Neotherix presenting at World Conference on Regenerative Medicine 2013
02/10/13 Smart Proof of Market award granted to Neotherix
30/09/13 Neotherix presenting at Regener8 Annual Conference 2013
26/09/13 Year in Industry Intern joins Neotherix team
19/07/13 House of Lords report on potential of regenerative medicine in the UK published
28/06/13 Mike Raxworthy invited to be a member of the newly-formed MedTech Skills National Workgroup
26/04/13 Two Neotherix patent applications published
12/04/13 Visiting CASE PhD student models Neotherix electrospinning process
18/03/13 Neotherix upgrades skills through specialist medical device training
24/01/13 Key patent granted in US
07/12/12 Neotherix exhibiting at Collaboration Nation - London, December 2012
28/11/12 Neotherix presenting at BioYorkshire 2012
18/10/12 Neotherix has joined Growth Accelerator!
16/10/12 Neotherix exhibiting at Nanofibres to Nanocomposites II event
26/09/12 Neotherix presenting at the Regener8 Annual Conference 2012
07/09/12 Neotherix participates in advanced woundcare mission to China
06/09/12 Neotherix represented on NanoRegen Mission to Germany and Austria.
11/06/12 Feasibility study funding awarded to Neotherix by Technology Strategy Board
28/05/12 Neotherix input into Electrospinning and Biomaterials conference presentations
27/04/12 Neotherix Scientist awarded Visiting Research Fellowship
19/03/12 National newspaper coverage for Neotherix story
28/02/12 New Technology Strategy Board funding for EktoTherix™
07/02/12 Neotherix attending Venturefest Yorkshire 2012
18/01/12 Mike Raxworthy to speak at Polymers in Regenerative Medicine symposium
05/12/11 Technology Strategy Board regenerative medicine funding winners announced
02/11/11 Neotherix to present at Nanofibres to Nanocomposites event
17/10/11 Neotherix is part of Health and Ageing Mission to US
06/10/11 Neotherix exhibiting at stand HW17 at Innovate '11
04/10/11 Neotherix to exhibit at Innovate '11
30/09/11 Feasibility study funding success for Neotherix and University of Manchester
26/09/11 Neotherix attending the Regener8 Annual Conference 2011
08/09/11 Oxford Investment Opportunity Network (OION) presentation scheduled for Neotherix
06/07/11 Neotherix to present at NanoRegen event
11/04/11 Open Innovation in China
03/03/11 IBIZ Invest 2011 presentation scheduled for Neotherix
28/02/11 Neotherix to be showcased at online Emerging Medical Technologies Spotlight event
14/02/11 Neotherix to exhibit at Venturefest Yorkshire 2011
11/02/11 Neotherix participates in trade mission to US
11/01/11 Neotherix awarded regeNer8 regenerative medicine project extension funding
10/12/10 Neotherix recognised among UK's pioneering healthcare technology companies
02/11/10 Neotherix to speak at Commercial Translation of Regenerative Medicine conference, 2010
07/10/10 Mike Raxworthy invited to judge Bioscience YES competition
23/09/10 Funding to aid development of skin cancer therapy
27/05/10 Neotherix embarks on Industrial CASE award project with the University of Manchester
01/03/10 New funding for Neotherix from Technology Strategy Board announced
25/02/10 Venturefest success for Neotherix
24/02/10 Mike Raxworthy back at NanoMedNet Nanomedicine Network
08/02/10 Neotherix to present and exhibit at Venturefest Yorkshire 2010
17/12/09 Neotherix to present at White Rose Work in Progress Meeting
19/11/09 Neotherix to exhibit at Annual bioProcessUK Conference
29/07/09 Neotherix success in regeNer8 Regenerative Medicine funding
03/07/09 Neotherix shortlisted for award at Medilink Innovation Day
29/05/09 Neotherix completes further stage of Access to Finance programme
28/05/09 Neotherix presents at NanoMedNet course
11/03/09 Additional RegeNer8 role for Mike Raxworthy
17/02/09 Neotherix expands its team
04/02/09 Neotherix to exhibit at Venturefest Yorkshire 2009
31/01/09 Neotherix to present at Senior Level Investment Meeting
02/10/08 Neotherix presents at YABA Investment Forum
07/08/08 Technology Strategy Board funding winners announced
08/04/08 Neotherix success in TSB application
20/12/07 Neotherix awarded White Rose grant
28/11/07 Neotherix presents at Connect Yorkshire Investment Forum
05/09/07 York-based company to pioneer skin repair for cancer sufferers

A new company just launched in York aims to pioneer a new treatment to repair the painful and unsightly wounds left by surgery to remove skin cancers.

Neotherix, a spin-out business from the global medical technologies company Smith & Nephew, has been set up to develop bioresorbable scaffolds that will help surgical lesions to heal without the need for skin grafts. Smith & Nephew have a continuing equity interest in Neotherix.

There are currently 100,000 new cases of skin cancer in the UK every year and global numbers have been rising by around 5% per year since the 1960s. Most skin cancers are highly treatable with high survival rates but, if not treated, may invade surrounding skin and cause disfigurement.

The technology being pioneered by Neotherix was initially developed for chronic wound applications by scientists at the Smith & Nephew Research Centre in York as part of a project part-funded by the regional development agency, Yorkshire Forward.

Smith & Nephew’s Advanced Wound Management Global Business Unit will continue to develop the technology for chronic wounds, but Neotherix will explore clinical applications outside of the company’s core markets.

The new venture is being led by Dr Mike Raxworthy and Dr Peter Iddon, who have transferred from the Research Centre to become Chief Executive Officer and Development Manager of the new company.

Mike Raxworthy said: “Skin cancer is often found in areas of the body where surgery or scarring is particularly noticeable like the face, neck and arms. Current repairs often rely on simply stitching up the wound left behind or grafting skin from another part of the body, which means a second surgical procedure and a second wound.”

“Our aim is to produce a scaffold that, when placed in the wound will actively help the tissue underneath to heal itself and be absorbed back into the body when its job is done. Although our initial efforts will be directed at the repair of skin cancer sites, we expect the technology to be suitable for use in a number of other surgical procedures.”

He added: “The first six months will focus on evaluating the technology and adapting it for this clinical application. After that we will be seeking backing to commercialise the treatment and we hope to have the product on the market by 2010.”

Close  |  Top of Page
© Copyright 2007-2017 Neotherix Ltd. All rights reserved.